Our Strategy

Industry Focused and Operational Oriented Middle Market Private Equity Firm

  • Industry specialization in Biologics, Pharmaceuticals, Medical Devices, Medical Technology, and Specialty Health Care Services
  • Seek buyout and growth financing investment opportunities in $20 million-$200 million enterprise value
  • Consistent with partner’s operating and investment expertise and track records
  • Consistent with corporate and personal network of relationships in target sectors

Disciplined Investment Approach Based Upon Proprietary Investment Thesis for Each Focus Sectors

  • The firm will remain disciplined and focused

Develop Strong Partnerships with Strong and Entrepreneurial Operators

  • Alignment of interest for value creation

Create Value through Growth, Operational Excellence and Increasingly Global Operations

  • Focused on large, fragmented and dynamic sectors
  • Transforming businesses to better meet market needs
  • Building businesses through innovation, operational excellence and increasingly global operations

Leverage Network to Originate Proprietary Investment Opportunities

  • The firm will aggressively leverage its proprietary network of deal originators and operating partners

Introduce World Class Operating Expertise to Emerging Companies

  • The firm will infuse world-class operators into every aspect of evaluation, execution and management of investments